Value through Innovation27 July 2016

What is a lay summary?

Clinical Study Results

  • MOBIC ® - Arthritis, Juvenile
    Clinical Study Number 107.208
    Study Indication Arthritis, Juvenile
    Product MOBIC ®
    Generic Name Meloxicam
    Lab Code
    Clinical Phase III
    Study Title

    A one year double-blind trial to investigate the efficacy and safety of meloxicam oral suspension 0.25 mg/kg and 0.125 mg/kg administered once daily in comparison to naproxen oral suspension 5 mg/kg administered twice daily in children with Juvenile Rheumatoid Arthritis

    Study Document
    Trial synopsis 107.208_CO english
  • MOBIC ® - Arthritis, Juvenile
    Clinical Study Number 107.235
    Study Indication Arthritis, Juvenile
    Product MOBIC ®
    Generic Name Meloxicam
    Lab Code
    Clinical Phase III
    Study Title

    A 12 week double-blind randomized trial, with a 12 week open-label extension, to investigate the efficacy and safety of meloxicam oral suspension administered once daily and naproxen oral suspension administered twice daily in children with Juvenile Rheumatoid Arthritis

    Study Document
    Trial synopsis 107.235_CO english